Stockreport

Bristol-Myers and Nektar Therapeutics to jointly develop cancer treatments [MarketWatch]

Nektar Therapeutics  (NKTR) 
Last nektar therapeutics earnings: 2/27 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.nektar.com/investor-relations
PDF Bristol-Myers and Nektar Therapeutics to jointly develop cancer treatments Bristol-Myers Squibb Co. BMY, +1.12% and Nektar Therapeutics NKTR, -3.86% said Wednesday [Read more]